Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
JCSE01 - Joint IASLC-CSCO-CAALC Session
- 07:00 - 11:15
- 9/07/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Joint IASLC-CSCO-CAALC Session
- Track:
- Moderators:Chunxue Bai, Tony Mok, Yi-Long Wu, Qing Zhou, Nan Wu
-
+
JCSE01.11 - Efficacy and Safety of Sintilimab with Anlotinib as First-Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
10:05 - 10:15 | Presenter: Baohui Han | Author(s): Tianqing Chu, Runbo Zhong, Hua Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, jialin Qian, Yuchen Han
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-41 - Involvement of the JNK Pathway in Bruceine D-Induced Apoptosis in Human Non-Small Cell Lung Cancer Cells
09:45 - 09:45 | Presenter: Bi qin Tan | Author(s): fei Wang, yu yu Huang, li hua Lan, bo Zhang, neng ming Lin
- Abstract
Loading... -
+
P1.01-95 - Efficacy and Safety of Anlotinib in Combination with Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
09:45 - 09:45 | Presenter: Tianqing Chu | Author(s): Baohui Han, Xueyan Zhang, Hua Zhong, Bo Zhang, Huimin Wang, Aiqin Gu, Wei Zhang, Chunlei Shi, Runbo Zhong
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-02 - Efficacy and Safety of Sintilimab with Anlotinib as First-Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Baohui Han | Author(s): Tianqing Chu, Runbo Zhong, Hua Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, jialin Qian, Yuchen Han
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-21 - Efficacy and Safety of Combing Anlotinib and Erlotinib as a First-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Tianqing Chu | Author(s): Baohui Han, Chunlei Shi, Hua Zhong, Wei Zhang, Bo Zhang, Runbo Zhong, Xueyan Zhang
- Abstract
Loading...
-
+
P2.11 - Screening and Early Detection
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Screening and Early Detection
-
+
P2.11-18 - Circulating Serum KLK5 and L1CAM Levels Potentially Predict Clinical Outcome to Anlotinib Therapy in NSCLC Patients
10:15 - 10:15 | Presenter: Jun Lu | Author(s): Qin Shi, Lele Zhang, Jun Wu, Bo Zhang, Shuyuan Wang, Xiaodong Zhao, Baohui Han
- Abstract
Loading...